complement
essenti
element
innat
acquir
immun
contribut
immunopathogenesi
mani
disord
includ
chaga
diseas
cd
human
complement
receptor
play
role
clearanc
complement
opson
molecul
may
facilit
entri
pathogen
host
cell
distinct
exon
variant
found
associ
express
level
increas
suscept
pathophysiolog
sever
diseas
studi
plasma
level
assess
elisa
variant
exon
sequenc
brazilian
cohort
chronic
cd
patient
healthi
control
level
significantli
decreas
cd
patient
compar
control
p
variant
significantli
associ
cd
high
linkag
disequilibrium
agagtg
haplotyp
associ
cruzi
infect
p
ci
wherea
agggtg
relat
risk
chagas
cardiomyopathi
p
ci
first
studi
provid
insight
role
develop
clinic
present
chronic
cd
chaga
diseas
cd
neglect
infecti
diseas
caus
intracellular
protozoan
parasit
trypanosoma
cruzi
cd
affect
five
million
peopl
latin
america
anoth
million
risk
acquir
infect
approxim
new
case
report
occur
year
approxim
patient
die
annual
human
migrat
contribut
substanti
current
global
scenario
cd
increas
number
case
nonendem
countri
epidemiolog
econom
social
implic
challeng
control
spread
cruzi
annual
cost
due
cd
global
us
billion
lifetim
cost
us
per
infect
individu
although
individu
infect
cruzi
remain
asymptomat
lifelong
approxim
infect
individu
progress
year
symptomat
form
diseas
develop
either
chronic
chagas
cardiomyopathi
ccc
digest
megasyndrom
patient
develop
lethal
cardiomyopathi
heart
transplant
remain
ultim
treatment
avail
ccc
inflammatori
condit
character
intens
immun
respons
initi
infect
proinflammatori
cytokin
produc
product
continu
along
chronic
phase
like
due
parasit
persist
among
other
persist
respons
lead
cardiac
commit
start
myocard
progress
ccc
transmiss
pathogen
triatomin
insect
vector
subfamili
triatomina
cruzi
use
sever
mechan
escap
host
immun
respons
among
evas
complement
attack
infect
form
cruzi
metacycl
trypomastigot
invad
almost
nucleat
cell
involv
wide
divers
receptor
kinin
receptor
tyrosin
kinas
transform
epiderm
growth
factor
receptor
lectin
receptor
fibronectin
tolllik
receptor
addit
receptor
cruzi
util
complement
molecul
promot
phagocytosi
lectin
protein
mannosebind
lectin
mbl
evad
host
immun
attack
promot
infect
evansoss
collabor
suggest
deposit
mbl
cruzi
parasit
surfac
play
role
infect
process
parasit
deactiv
lectin
complement
pathway
ultim
could
favor
cruzi
cell
intern
mediat
receptor
molecul
includ
complement
system
essenti
innat
acquir
immun
contribut
immunopathogenesi
varieti
diseas
includ
cd
multifunct
polymorph
glycoprotein
occur
solubl
transmembran
protein
express
peripher
blood
cell
includ
monocyt
erythrocyt
natur
killer
cell
well
b
cell
known
enhanc
phagocytosi
particl
opson
mbl
well
facilit
clearanc
immun
complex
bind
erythrocyt
macrophag
dispos
gene
locat
chromosom
omim
belong
regul
complement
activ
famili
character
small
consensu
repeat
also
known
complement
control
protein
repeat
genet
variabl
may
influenc
express
includ
molecular
weight
densiti
molecul
cell
surfac
demonstr
involv
pathogenesi
sever
infecti
diseas
either
facilit
pathogen
entri
host
cell
case
downmodul
complement
activ
other
shown
mediat
immun
opson
leishmania
amastigot
promastigot
plasmodium
falciparum
mycobacterium
tuberculosi
lepra
hiv
sarscov
adenoviru
hepat
c
viru
west
nile
viru
besid
role
facilit
entri
intracellular
pathogen
host
cell
protein
level
shown
associ
pathogenesi
differ
diseas
includ
malaria
tuberculosi
lepromat
leprosi
sever
acut
respiratori
syndrom
chronic
liver
diseas
hiv
infect
among
other
genet
variant
exon
evalu
studi
particular
interest
sinc
nonsynonym
variant
http
wwwensembl
org
situat
bind
site
ficolin
mbl
therebi
potenti
influenc
complement
induc
phagocytosi
present
studi
aim
assess
genet
variant
exon
level
associ
develop
clinic
present
chronic
cd
plasma
level
plasma
level
significantli
lower
cd
patient
compar
control
p
fig
compar
control
clinic
form
separ
statist
differ
also
observ
level
control
indetermin
form
p
cardiac
form
p
digest
form
p
cardiodigest
form
p
fig
comparison
level
asymptomat
indetermin
form
symptomat
patient
show
statist
differ
associ
variant
chaga
diseas
distribut
genotyp
control
hardyweinberg
equilibrium
p
patient
chronic
cd
three
snp
hw
equilibrium
may
due
diseas
associ
frequenc
variant
p
ci
p
ci
p
ci
significantli
higher
cd
patient
compar
control
tabl
also
frequenc
genotyp
p
ci
p
ci
significantli
higher
chronic
cd
patient
control
tabl
analyz
cd
patient
accord
clinic
present
relat
control
allel
occur
frequent
among
asymptomat
indetermin
form
cd
p
ci
patient
present
digest
form
cd
p
ci
tabl
addit
carrier
g
allel
rather
present
among
asymptomat
patient
control
p
ci
tabl
signific
associ
cardiac
form
found
also
minor
g
allel
p
ci
g
carrier
ag
gg
p
ci
tabl
patient
cardiomyopathi
grade
accord
classif
cardiomyopathi
outlin
method
section
compar
asymptomat
patient
allel
occur
frequent
patient
cardiomyopathi
without
echo
alter
p
ci
patient
cardiomyopathi
without
heart
failur
p
ci
asymptomat
patient
genotyp
observ
frequent
among
patient
cardiomyopathi
without
echo
alter
p
ci
patient
cardiomyopathi
without
heart
failur
p
ci
patient
without
overt
symptom
tabl
compar
patient
cardiomyopathi
consid
differ
stage
cardiac
patholog
allel
p
ci
genotyp
p
ci
frequent
patient
without
heart
failur
heart
failur
tabl
associ
haplotyp
chaga
diseas
total
haplotyp
observ
reconstruct
six
variant
investig
studi
fig
frequenc
agagtg
haplotyp
significantli
increas
among
cd
patient
p
ci
patient
cardiomyopathi
without
echo
alter
p
ci
cardiomyopathi
patient
without
heart
failur
p
ci
among
control
addit
agggtg
significantli
associ
cardiomyopathi
p
ci
absenc
heart
failur
p
ci
comparison
control
tabl
linkag
disequilibrium
ld
pattern
variant
given
fig
strong
ld
observ
chronic
cd
patient
ld
plot
indic
strong
ld
therefor
also
strong
ld
order
maintain
life
cycl
transmiss
triatomin
vector
human
host
cruzi
need
evad
host
immun
attack
develop
intracellularli
success
entranc
cruzi
host
cell
depend
downregul
complement
activ
parasit
regulatori
molecul
bind
complement
receptor
thu
complement
system
import
role
establish
cruzi
infect
susten
chronic
phase
studi
genet
variant
exon
investig
patient
chronic
cd
order
assess
role
modul
level
well
develop
clinic
progress
diseas
patient
chronic
cd
significantli
decreas
level
compar
healthi
control
plasma
level
observ
control
group
accord
report
studi
reduc
express
erythrocyt
combin
increas
level
immun
complex
demonstr
pathogenesi
hiv
sarscov
tuberculosi
lepra
infect
leprosi
aid
tuberculosi
reduct
level
diseas
regul
demonstr
condit
acquir
rather
inherit
moreov
known
similarli
mechan
use
pathogen
cruzi
use
promot
phagocytosi
well
mbl
promot
opson
via
strategi
evad
host
immun
system
infect
host
cell
interestingli
patient
cardiomyopathi
lower
plasma
level
asymptomat
patient
might
indic
either
consumpt
due
increas
complement
activ
lower
product
associ
clinic
manifest
fact
chagas
cardiomyopathi
known
associ
inflammatori
process
tissu
damag
observ
variou
inflammatori
infecti
condit
moreov
one
consequ
persist
myocardi
damag
cd
left
ventricular
dilat
systol
dysfunct
reason
left
ventricular
systol
function
evalu
cd
patient
use
left
ventricular
eject
fraction
lvef
despit
import
role
complement
system
cardiovascular
diseas
atherosclerosi
myocardi
infarct
acut
ischaem
stroke
correl
level
lvef
found
find
corrobor
data
studi
patient
acut
myocardi
infarct
known
level
may
influenc
infect
express
associ
genet
well
acquir
factor
observ
studi
lower
level
associ
genotyp
control
patient
two
studi
found
genotyp
associ
lower
erythrocyt
sediment
rate
preterm
birth
find
indic
genotyp
may
modul
express
sinc
associ
level
patient
reduct
level
chronic
cd
probabl
due
diseas
process
antiinflammatori
role
alreadi
observ
experiment
studi
abl
prevent
tissu
injuri
induc
complement
activ
consid
chronic
cd
associ
inflamm
possibl
low
level
cd
patient
may
relat
antiinflammatori
effect
consumpt
due
complement
activ
howev
exact
mechan
control
express
cd
patient
still
unclear
posit
associ
ag
gg
genotyp
variant
g
allel
variant
observ
chronic
cd
may
relat
function
properti
molecul
variant
lead
substitut
amino
acid
molecul
may
affect
fold
affin
allel
also
relat
low
ratio
express
erythrocyt
membran
addit
allel
previous
associ
sever
malaria
sickl
cell
anemia
show
protect
effect
lepra
tuberculosi
infect
allel
increas
risk
alzheim
diseas
gastric
cancer
nonsmal
cell
lung
cancer
preterm
birth
moreov
allel
agggtg
agagtg
haplotyp
relat
earli
stage
cd
cardiac
form
indic
variant
might
predispos
clinic
progress
chronic
patient
cd
sinc
pathogenesi
ccc
involv
parasit
persist
differ
tissu
well
continu
lowgrad
parasitemia
inflammatori
process
immun
mediatedmyocardi
injuri
possibl
protein
product
variant
may
augment
cruzi
bind
consequ
cellular
intern
besid
immunomodulatori
effect
limit
present
studi
lack
baselin
plasma
level
patient
acut
cd
acut
cd
patient
difficult
diagnos
clinic
henc
measur
level
possibl
earli
stage
infect
might
serv
baselin
measur
ambulatori
chaga
diseas
hospit
da
feder
univers
enrol
chronic
cd
patient
thu
make
access
acut
cd
patient
imposs
conclus
studi
report
variant
associ
risk
cruzi
infect
progress
chagas
cardiomyopathi
besid
low
level
observ
cd
patient
possibl
due
diseas
process
first
studi
provid
insight
role
develop
clinic
present
chronic
cd
nevertheless
studi
necessari
confirm
find
statist
analysi
plasma
level
compar
group
use
nonparametr
kruskalw
mannwhitney
test
distribut
variabl
assess
shapirowilk
test
multipl
logist
regress
execut
adjust
age
sex
ethnic
group
multipl
comparison
correct
use
benjaminihochberg
procedur
appli
fals
discoveri
rate
raw
pvalu
remain
signific
correct
consid
studi
odd
ratio
confid
interv
ci
calcul
use
stata
softwar
v
statacorp
colleg
station
texa
usa
correl
analys
perform
nonparametr
spearman
rank
coeffici
test
allel
frequenc
obtain
direct
count
genotyp
haplotyp
frequenc
analyz
gene
count
expectationmaximum
em
algorithm
signific
deviat
hardyweinberg
equilibrium
test
use
randompermut
procedur
implement
arlequin
v
softwar
http
lgbunigecharlequin
linkag
disequilibrium
ld
analysi
perform
use
haploview
v
http
broadinstituteorghaploview
possibl
associ
allel
genotyp
haplotyp
differ
clinic
form
evalu
twotail
fisher
exact
test
pvalu
consid
signific
